Recent Updates
Recently added Catalysts
ACHC Positive Sentiment

Acadia Partners with Orlando Health in Construction of New Hospital

Thursday, February 15, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Acadia and Orlando Health have initiated the construction of a new 144-bed behavioral health hospital in Apopka, Florida, with a groundbreaking ceremony held on February 15. The facility is expected to open in 2025 and will offer inpatient and intensive outpatient treatment for various age groups. This development aims to improve access to essential mental health services in the Orlando metropolitan area.
Price reaction · baseline $83.2 (2024-02-15 close) · hit after-hours · clean, no other ACHC news in the window
day 0 close · peak
-0.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • New hospital will enhance behavioral health services in the area.
  • Facility aims to provide treatment for a diverse age range.
  • Groundbreaking event indicates strong community investment.

Full Press Release Details

Acadia and Orlando Health held a groundbreaking ceremony February 15 for a new 144-bed behavioral health hospital in Apopka, Florida. The state-of-the-art hospital is slated to open in 2025 and will provide inpatient and intensive outpatient treatment for children, adolescents, adults, and senior adults, expanding access to much-needed services in the Orlando metro area.
Read More

Frequently Asked Questions

When is the new hospital expected to open?

The new hospital is slated to open in 2025.

What services will the new hospital provide?

It will provide inpatient and intensive outpatient treatment for all age groups.

Where is the new hospital located?

The new hospital will be located in Apopka, Florida.

Who partnered with Acadia for this project?

Acadia partnered with Orlando Health for the construction of the hospital.

ShareAdd on Google
Tags: ACHC Viatris Investor Conferences Healthcare Acadia Orlando Health behavioral health hospital construction Florida
Last updated: Feb 15, 2024

Biotech snapshot

Cash runway
$171M liquidity · $0M/mo burn
Low dilution risk